Mari Hämäläinen

Aktiviteetit

Aktiviteetteja vuodessa 2008 2013 2017 2018 2019 2022

• 199 Konferenssiesitelmä
• 5 Kutsuttu esitelmä

Aktiviteetteja vuodessa

Hakutulokset

• Health promoting effects of lingonberry in obesity: impact on weight gain, glucose and lipid levels, and low-grade inflammation in high-fat diet induced obesity model in mice

  Riitta Ryyti (Speaker), Mari Hämäläinen (Contributor), Antti Pemmari (Contributor), Rainer Peltola (Contributor) & Eeva Moilanen (Contributor)

  24 marrask. 2022 → 25 marrask. 2022

  Aktiviteetti: Konferenssiesitelmä

• Inflammatory glycoprotein YKL-40 is elevated after coronary artery bypass surgery and correlates with leukocyte chemotaxis and myocardial injury, a pilot study

  Antti Laurikka (Speaker), Katriina Vuolteenaho (Contributor), Vesa Toikkanen (Contributor), Timo Rinne (Contributor), Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Matti Tarkka (Contributor), Jari Laurikka (Contributor) & Eeva Moilanen (Contributor)

  24 marrask. 2022 → 25 marrask. 2022

  Aktiviteetti: Konferenssiesitelmä

• The regulation of TRPA1 expression and function by Th1- and Th2-type inflammation in human A549 lung epithelial cells

  Samu Luostarinen (Speaker), Mari Hämäläinen (Contributor), Antti Pemmari (Contributor) & Eeva Moilanen (Contributor)

  24 marrask. 2022 → 25 marrask. 2022

  Aktiviteetti: Konferenssiesitelmä

• The glucocorticoid dexamethasone alleviates acute allergic inflammatory reaction through an MKP-1 dependent mechanism

  Tiina Lehtola (Speaker), Elina Nummenmaa (Contributor), Riina Nieminen (Contributor), Mari Hämäläinen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  24 marrask. 2022 → 25 marrask. 2022

  Aktiviteetti: Konferenssiesitelmä

• Lakan terveysvaikutukset

  Eeva Moilanen (Speaker), Toini Pemmari (Contributor), Mari Hämäläinen (Contributor), Riitta Ryyti (Contributor) & Rainer Peltola (Contributor)

  8 marrask. 2022

  Aktiviteetti: Konferenssiesitelmä

• Effects of a selective inhibitor of the inducible prostaglandin E synthase-1 (mPGES-1) in human OA chondrocytes: RNA-Seq-based study

  Lauri Tuure (Speaker), Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Teemu Moilanen (Contributor) & Eeva Moilanen (Contributor)

  24 elok. 2022 → 26 elok. 2022

  Aktiviteetti: Konferenssiesitelmä

• The inflammatory regulation of TRPA1 expression in human A549 lung epithelial cells

  Samu Luostarinen (Speaker), Mari Hämäläinen (Contributor), Noriyuki Hatano (Contributor), Katsuhiko Muraki (Contributor) & Eeva Moilanen (Contributor)

  24 elok. 2022 → 26 elok. 2022

  Aktiviteetti: Konferenssiesitelmä

• Health-promoting effects of lingonberry in obesity: impact on weight gain, glucose and lipid levels, and low-grade inflammation in high-fat diet-induced obesity model in mice

  Riitta Ryyti (Speaker), Mari Hämäläinen (Contributor), Antti Pemmari (Contributor), Rainer Peltola (Contributor) & Eeva Moilanen (Contributor)

  24 elok. 2022 → 26 elok. 2022

  Aktiviteetti: Konferenssiesitelmä

• TRPA1 mediates DNCB-induced allergic contact dermatitis

  Ilari Mäki-Opas (Speaker), Mari Hämäläinen (Contributor), Lauri Moilanen (Contributor), Heini Sood (Contributor), Tiina Leppänen (Contributor), Lauri Lehtimäki (Contributor) & Eeva Moilanen (Contributor)

  24 elok. 2022 → 26 elok. 2022

  Aktiviteetti: Konferenssiesitelmä

• TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1 deficient mice in experimentally induced scleroderma

  Ilari Mäki-Opas (Speaker), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor) & Morena Scotece (Contributor)

  5 toukok. 2022 → 6 toukok. 2022

  Aktiviteetti: Konferenssiesitelmä

• Chondrocytes from osteoarthritis patients adopt distinct phenotypes in response to central Th1/Th2/Th17 cytokines

  Antti Pemmari (Speaker), Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Teemu Moilanen (Contributor) & Eeva Moilanen (Contributor)

  5 toukok. 2022 → 6 toukok. 2022

  Aktiviteetti: Konferenssiesitelmä

• Dexamethasone attenuates MMP-13 expression through MKP-1 in chondrocytes

  Tiina Lehtola (Speaker), Lauri Tuure (Contributor), Mari Hämäläinen (Contributor), Riina Nieminen (Contributor), Teemu Moilanen (Contributor), Antti Pemmari (Contributor) & Eeva Moilanen (Contributor)

  5 toukok. 2022 → 6 toukok. 2022

  Aktiviteetti: Konferenssiesitelmä

• Dexamethasone attenuates MMP-13 expression through MKP-1 in chondrocytes

  Tiina Lehtola (Speaker), Elina Nummenmaa (Contributor), Lauri Tuure (Contributor), Mari Hämäläinen (Contributor), Riina Nieminen (Contributor), Teemu Moilanen (Contributor), Antti Pemmari (Contributor) & Eeva Moilanen (Contributor)

  25 marrask. 2021 → 26 marrask. 2021

  Aktiviteetti: Konferenssiesitelmä

• Pro-inflammatory cytokines induce the expression of functional TRPA1 (transient receptor potential ankyrin 1) in human A549 lung epithelial cells

  Samu Luostarinen (Speaker), Mari Hämäläinen (Contributor), Noriyuki Hatano (Contributor), Katsuhiko Muraki (Contributor) & Eeva Moilanen (Contributor)

  25 marrask. 2021 → 26 marrask. 2021

  Aktiviteetti: Konferenssiesitelmä

• Bilberry (Vaccinium myrtillus L.) alleviates inflammation and adverse metabolic effects caused by high-fat diet in a mouse model

  Toini Pemmari (Speaker), Mari Hämäläinen (Contributor), Riitta Ryyti (Contributor), Rainer Peltola (Contributor) & Eeva Moilanen (Contributor)

  25 marrask. 2021 → 26 marrask. 2021

  Aktiviteetti: Konferenssiesitelmä

• TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1 deficient mice in experimentally induced scleroderma

  Ilari Mäki-Opas (Speaker), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor) & Morena Scotece (Contributor)

  25 marrask. 2021 → 26 marrask. 2021

  Aktiviteetti: Konferenssiesitelmä

• Pinosylvin shifts macrophage polarization to support resolution of inflammation

  Konsta Kivimäki (Speaker), Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  25 marrask. 2021 → 26 marrask. 2021

  Aktiviteetti: Konferenssiesitelmä

• TRPA1 as a factor in osteoarthritis: TRPA1 (transient receptor potential ankyrin 1) mediates fibroblast growth factor-2 expression in chondrocytes

  Elina Nummenmaa (Speaker), Mari Hämäläinen (Contributor), Antti Pemmari (Contributor), Lauri Moilanen (Contributor), Riina Nieminen (Contributor), Teemu Moilanen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  25 marrask. 2021 → 26 marrask. 2021

  Aktiviteetti: Konferenssiesitelmä

• Chondrocytes from osteoarthritis patients adopt distinct phenotypes in response to central Th1/Th2/Th17 cytokines

  Antti Pemmari (Speaker), Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Teemu Moilanen (Contributor) & Eeva Moilanen (Contributor)

  25 marrask. 2021 → 26 marrask. 2021

  Aktiviteetti: Konferenssiesitelmä

• Health-promoting effects of lingonberry (Vaccinium vitis-idaea L.) in obesity: impact on lipid and glucose metabolism and low-grade inflammation

  Riitta Ryyti (Speaker), Mari Hämäläinen (Contributor), Antti Pemmari (Contributor), Rainer Peltola (Contributor) & Eeva Moilanen (Contributor)

  13 heinäk. 2021 → 15 heinäk. 2021

  Aktiviteetti: Konferenssiesitelmä

• The inflammatory regulation of TRPA1 expression in human A549 lung epithelial cells

  S Luostarinen (Contributor), M Hämäläinen (Contributor), N Hatano (Contributor), K Muraki (Contributor) & E Moilanen (Contributor)

  13 helmik. 2020

  Aktiviteetti: Konferenssiesitelmä

• The inflammatory regulation of transient receptor potential ankyrin-1 gene expression in human A549 lung epithelial cells

  S Luostarinen (Contributor), S Hämäläinen (Contributor), M Hatano (Contributor), N Muraki (Contributor) & K Moilanen (Contributor)

  29 marrask. 2019

  Aktiviteetti: Konferenssiesitelmä

• Anti-inflammatory mechanisms of PDE4 inhibitors: Rolipram induces macrophage polarization from inflammatory (M1) to healing promoting (M2) phenotype through MKP-1

  Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  29 marrask. 2019

  Aktiviteetti: Konferenssiesitelmä

• Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes

  E Nummenmaa (Contributor), M Hämäläinen (Contributor), A Pemmari (Contributor), E Moilanen (Contributor), LJ Moilanen (Contributor), R Nieminen (Contributor), K Vuolteenaho (Contributor) & T Moilanen (Contributor)

  29 marrask. 2019

  Aktiviteetti: Konferenssiesitelmä

• TRPA1 mediates DNCB-induced allergic contact dermatitis

  I Mäki-Opas (Contributor), M Hämäläinen (Contributor), LJ Moilanen (Contributor), H Sood (Contributor), T Leppänen (Contributor), L Lehtimäki (Contributor) & E Moilanen (Contributor)

  29 marrask. 2019

  Aktiviteetti: Konferenssiesitelmä

• Effects of a selective inhibitor of inducible prostaglandin E synthase-1 (mPGES-1) in human OA chondrocytes: RNA-Seq-based study

  L Tuure (Contributor), A Pemmari (Contributor), M Hämäläinen (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)

  29 marrask. 2019

  Aktiviteetti: Konferenssiesitelmä

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  29 marrask. 2019

  Aktiviteetti: Konferenssiesitelmä

• YKL-40, IL-8 and IL-6 in clusters of adult-onset asthma

  P Ilmarinen (Contributor), LE Tuomisto (Contributor), O Niemelä (Contributor), M Hämäläinen (Contributor), E Moilanen (Contributor) & H Kankaanranta (Contributor)

  28 syysk. 2019

  Aktiviteetti: Konferenssiesitelmä

• Anti-inflammatory mechanisms of PDE4 inhibitors: Rolipram induces macrophage polarization from inflammatory (M1) to healing promoting (M2) phenotype through MKP-1 phosphatase

  Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  15 syysk. 2019

  Aktiviteetti: Konferenssiesitelmä

• Health-promoting effects of lingonberry in obesity: impact on weight gain, glucose and lipid levels and low-grade inflammation

  Mari Hämäläinen (Contributor) & Eeva Moilanen (Contributor)

  15 syysk. 2019

  Aktiviteetti: Konferenssiesitelmä

• CAMP enhancing drugs salbutamol and rolipram augment the alternative activation of murine macrophages through MKP-1

  I Mäki-Opas (Contributor), M Scotece (Contributor), M Hämäläinen (Contributor) & E Moilanen (Contributor)

  15 syysk. 2019

  Aktiviteetti: Konferenssiesitelmä

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  A Pemmari (Contributor), L Tuure (Contributor), M Hämäläinen (Contributor), T Leppänen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)

  2 toukok. 2019

  Aktiviteetti: Konferenssiesitelmä

• Transient receptor potential ankyrin 1 (TRPA1) as a factor and drug target in osteoarthritis: TRPA1 mediates fibroblast growth factor 2 expression in chondrocytes

  Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Antti Pemmari (Contributor) & Katriina Vuolteenaho (Contributor)

  2 toukok. 2019

  Aktiviteetti: Konferenssiesitelmä

• CAMP enhancing drugs salbutamol and rolipram augment alternative macrophage activation through MKP-1

  T Kivistö (Contributor), M Scotece (Contributor), M Hämäläinen (Contributor) & E Moilanen (Contributor)

  20 maalisk. 2019

  Aktiviteetti: Konferenssiesitelmä

• Transient receptor potential ankyrin 1 (TRPA1) mediates fibroblast growth factor-2 (FGF-2) expression in chondrocytes

  Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Antti Pemmari (Contributor) & Katriina Vuolteenaho (Contributor)

  20 maalisk. 2019

  Aktiviteetti: Konferenssiesitelmä

• Transient receptor potential ankyrin-1 is an inflammation-induced factor in human keratinocytes and promotes the expression of inflammatory genes in vitro

  S Luostarinen (Contributor), M Hämäläinen (Contributor) & E Moilanen (Contributor)

  20 maalisk. 2019

  Aktiviteetti: Konferenssiesitelmä

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  20 maalisk. 2019

  Aktiviteetti: Konferenssiesitelmä

• Transient receptor potential ankyrin-1 is an inflammation-induced factor in human keratinocytes and promotes the expression of inflammatory genes in vitro

  Samu Luostarinen (Speaker), Mari Hämäläinen (Speaker) & Eeva Moilanen (Speaker)

  24 tammik. 2019

  Aktiviteetti: Konferenssiesitelmä

• Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes

  Elina Nummenmaa (Speaker), Mari Hämäläinen (Speaker), Eeva Moilanen (Speaker), Riina Nieminen (Speaker) & Katriina Vuolteenaho (Speaker)

  24 tammik. 2019

  Aktiviteetti: Konferenssiesitelmä

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  A Pemmari (Speaker), L Tuure (Speaker), M Hämäläinen (Speaker), T Leppänen (Speaker), K Vuolteenaho (Speaker), T Moilanen (Speaker) & E Moilanen (Speaker)

  24 tammik. 2019

  Aktiviteetti: Konferenssiesitelmä

• PDE4 inhibitor rolipram augments the alternative activation of murine macrophages through MKP-1

  Tiina Leppänen (Speaker), Mari Hämäläinen (Speaker), Eeva Moilanen (Speaker), Tiina Myyry (Speaker) & Riina Nieminen (Speaker)

  24 tammik. 2019

  Aktiviteetti: Konferenssiesitelmä

• Effects of a selective inhibitor of inducible prostaglandin E synthase (mPGES-1) in human OA chondrocytes: RNA-Seq-based study

  Lauri Tuure (Speaker), Mari Hämäläinen (Speaker) & Eeva Moilanen (Speaker)

  24 tammik. 2019

  Aktiviteetti: Konferenssiesitelmä

• Adipokines and disease activity in patients with newly diagnosed inflammatory joint diseases

  A Kononoff (Speaker), K Vuolteenaho (Speaker), M Hämäläinen (Speaker), H Kautiainen (Speaker), P Elfving (Speaker), E Savolainen (Speaker), L Arstila (Speaker), H Niinisalo (Speaker), J Rutanen (Speaker), O Marjoniemi (Speaker), E Moilanen (Speaker) & O Kaipiainen-Seppänen (Speaker)

  24 tammik. 2019

  Aktiviteetti: Konferenssiesitelmä

• CAMP enhancing drugs salbutamol and rolipram augment the alternative activation of murine macrophages through MKP-1

  Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor) & Eeva Moilanen (Contributor)

  23 marrask. 2018

  Aktiviteetti: Konferenssiesitelmä

• IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin

  M Laavola (Contributor), T Leppänen (Contributor), M Hämäläinen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor), R Nieminen (Contributor) & E Moilanen (Contributor)

  23 marrask. 2018

  Aktiviteetti: Konferenssiesitelmä

• MAP kinase phosphatase-1 (MKP-1) as a target of anti-inflammatory drug treatment: Anti-inflammatory effects of the glucocorticoid dexamethasone are mediated by MKP-1 in murine models

  R Nieminen (Contributor), A Pemmari (Contributor), M Hämäläinen (Contributor), T Leppänen (Contributor) & E Moilanen (Contributor)

  23 marrask. 2018

  Aktiviteetti: Konferenssiesitelmä

• Transient receptor potential ankyrin 1 (TRPA1) is an inflammation-induced factor in human keratinocytes and promotes the expression of inflammatory genes in vitro

  S Luostarinen (Contributor), M Hämäläinen (Contributor) & E Moilanen (Contributor)

  23 marrask. 2018

  Aktiviteetti: Konferenssiesitelmä

• Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients

  Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  23 marrask. 2018

  Aktiviteetti: Konferenssiesitelmä

• MKP-1 as a novel factor in the pathogenesis of scleroderma. An experimental study

  Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  23 marrask. 2018

  Aktiviteetti: Konferenssiesitelmä

• Anti-inflammatory properties of the ?2-receptor agonist salbutamol and the PDE4 inhibitor rolipram are mediated by MKP-1

  Mari Hämäläinen (Contributor), Riku Korhonen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  23 marrask. 2018

  Aktiviteetti: Konferenssiesitelmä